GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sudarshan Pharma Industries Ltd

Sudarshan Pharma Allots 90 Lakh Equity Shares via Warrant Conversion

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 12 Jun 2026, 08:01 PM IST  ·  BSE ID: 0ae34468-f34d-4c5c-8b61-8a48e7842067
View Original BSE Filing (PDF)
💡
In Simple Terms
Sudarshan Pharma issued new shares to promoters after they completed payment for warrants, increasing its total capital.
🤖 AI Summary
  • Sudarshan Pharma allotted 90,00,000 equity shares from warrant conversion.
  • The conversion is for the Promoter Category upon receipt of balance amount.
  • Issue price per share is Rs.16.983 (including Rs.15.983 premium).
  • Post-allotment, paid-up capital increases to Rs.24,96,58,870.
  • The allotment is pursuant to SEBI (ICDR) Regulations, 2018.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of equity shares allotted
90,00,000
Face value per equity share
Re.1/-
Issue price per equity share
Rs.16.983/-
Premium per equity share
Rs.15.983/-
Number of warrants converted
9,00,000
Balance amount received for warrants
Rs.11,46,35,250/-
Exercise price per warrant
Rs.127.37/-
Post allotment paid-up share capital
Rs.24,96,58,870/-
Post allotment total equity shares
24,96,58,870
Promoter / Promoter Group shareholding
58.93%
Non-promoter shareholding
41.07%
🏢 How This Affects the Company
💰
Financial Impact
The company's issued and paid-up equity share capital has increased to Rs.24,96,58,870, consisting of 24,96,58,870 equity shares of Re.1/- each.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this allotment.
👤
Who Is Affected
Shareholders are affected by the increase in the total number of equity shares, impacting equity structure. Promoter/Promoter Group shareholding is now 58.93% and Non-promoter is 41.07%.
🔍
Management Signal
Management signals intent to finalize capital raising from promoters and increase paid-up capital as planned.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of new shareholding patterns.
Disclosure of funds utilization for raised capital.
Future board meeting minutes on strategic decisions.
LOW RISK Routine preferential allotment completion; no new material risks identified in filing.
💡 Investor Takeaway
Sudarshan Pharma completed conversion of 9,00,000 warrants, allotting 90,00,000 equity shares to promoters at Rs.16.983 each, increasing paid-up capital to Rs.24,96,58,870.
⚖️ Strengths & Concerns

✅ Positives

  • Completion of warrant conversion by promoter category signals commitment and capital infusion.
  • Increased paid-up capital to Rs.24,96,58,870 strengthens the company's financial base.
❓ Frequently Asked Questions
How many equity shares did Sudarshan Pharma Industries allot?
Sudarshan Pharma Industries allotted 90,00,000 equity shares of face value Re.1/- each.
What was the issue price for the newly allotted equity shares?
The issue price was Rs.16.983 per equity share, including a premium of Rs.15.983.
Who were the allottees of these new equity shares?
The 90,00,000 equity shares were allotted to persons belonging to the 'Promoter Category'.
How did this allotment affect Sudarshan Pharma's paid-up capital?
The allotment increased the company's issued and paid-up share capital to Rs.24,96,58,870.
What is the current promoter shareholding after the allotment?
Post-allotment, the promoter/promoter group shareholding stands at 58.93%.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.